Category: clinical trial

0

Clinical Study Coordinators & Monitors in Thailand: Qualifications, Responsibilities, & Regulatory Compliance

In the realm of clinical research in Thailand, clinical study coordinators and monitors play a vital role in ensuring the smooth execution of trials while adhering to regulatory compliance. Clinical study coordinators and monitors play pivotal roles in Thailand’s dynamic clinical research landscape. These dedicated professionals are at the forefront of ensuring the successful implementation […]

Read More →
0

Comprehensive Site SOP for Clinical Trials: Standardizing Processes for ICH GCP Compliance

A comprehensive site SOP for clinical trials is a detailed and all-encompassing document. It outlines the standardized procedures and guidelines to ensure adherence to the ICH GCP guidelines within a clinical trial site. A Site SOP establishes a specific set of standardized procedures and guidelines for a particular clinical trial site. It aims to ensure […]

Read More →
0

The Role of IOR & EOR Services In Optimizing Clinical Trials In Japan

The role of IOR & EOR services is becoming crucial in optimizing clinical trials in Japan. Clinical trials are essential for the development of new drugs and medical devices. Japan, being a significant player in the pharmaceutical industry, has become an attractive location for conducting clinical trials. This is due to its diverse patient population, […]

Read More →
0

Why Accurate Translation Is Crucial For Successful Clinical Trials?

Accurate translation is essential for successful clinical trials. It ensures that participants understand the study procedures, risks, benefits, and potential adverse events. Inaccurate translation can lead to misunderstandings that impact the validity of study results. Accurate translation of study documents is crucial for consistency and minimizing errors during data collection and analysis. Regulatory non-compliance with […]

Read More →
0

The Importance Of Translation In Clinical Trials

Translation plays a crucial role in facilitating accurate communication between participants, researchers, and sponsors in conducting clinical trials on a global scale. This can be a challenging task, especially when language barriers come into play. Clinical trials are critical for developing new drugs, medical devices, and treatments. These trials aim to test the safety, efficacy, […]

Read More →
0

Psychiatry Clinical Trials: Important Considerations For Designing

Designing clinical trials in psychiatry is challenging compared to a regular clinical trial. Clinicians and instructors have to handle participants who are mentally ill. They have to assume numerous factors before the clinical trial, where the main issue is taking informed consent, populations, measuring end-points, etc.  There are many ethical laws and criteria for designing […]

Read More →
0

Rare Diseases Sites Worldwide

The number of clinical trials in rare diseases is growing drastically from the last ten years to more than 500 compared to a few hundred clinical trials. Currently, more than 400 orphan designated drugs are commercially available, and around 1000 drugs are undergoing clinical trials. But still, the clinical trials in rare diseases present many […]

Read More →
0

Rare Disease Day 2020: Taking a step further

Many people with rare diseases struggle to find the right diagnosis and right treatment for years. The lack of awareness about these conditions makes it much harder for them to get the right treatment. Rare Disease Day is all about raising awareness for rare diseases. And, this year, you can join these efforts too. The […]

Read More →
3

Rare Diseases: Regulatory Incentives for Development of Orphan Drugs – Asia

In recent years, there is a huge leap in the pharma industry towards rare disease research and orphan drug developments due to the great support from regulatory authorities such as faster approval timelines, supportive regulatory frameworks, financial incentives, and many more. Currently, large pharmaceutical companies like Novartis, GSK, Roche, and Pfizer are extremely active in […]

Read More →
4

Rare Diseases: Regulatory Incentives for Development of Orphan Drugs – JAPAN & AUSTRALIA

Regulatory agencies in various countries are providing benefits & regulatory incentives for orphan drugs such as faster approvals, fee concessions, and financial benefits, and many more. These incentives are to support and encourage pharma companies to work on developing orphan drugs or medical devices for rare diseases. The countries that provide regulatory incentives include the […]

Read More →